DCL INTRODUCES WIDE RANGE CRP ASSAY

DCL’S LIQUID-STABLE MICROALBUMIN ASSAY RECEIVES FDA CLEARANCE FOR HUMAN TESTING

DCL INTRODUCES ALANINE AMINOTRANSFERASE L3K^® (ALT L3K) LIQUID STABLE REAGENT

DCL LAUNCHES NEW HDL-ADVANCE™ AND LDL-ADVANCE™ ASSAYS

L3K^® LINE OF LIQUID STABLE CHEMISTRY REAGENTS AVAILABLE FROM DCL

SORBITOL DEHYDROGENASE (SDH) CONTROL MATERIAL AVAILABLE FROM DCL

DCL LAUNCHES PROTEIN CLEARING IRON ASSAY

PLASMA TESTING NOW POSSIBLE WITH DCL’S CARBON DIOXIDE– L3K^® REAGENT

DCL ANNOUNCES AVAILABILITY OF DIAGNOSTIC REAGENTS FOR VETERINARY APPLICATIONS

DCL’S ACETAMINOPHEN-SL ASSAY RECEIVES FDA CLEARANCE FOR PLASMA TESTING

DCL’s SALICYLATE–SL ASSAY APPROVED FOR TESTING WITH HUMAN PLASMA

DCL INTRODUCES NEW HDL- ADVANCE™ AND LDL-ADVANCE™ CALIBRATION MATERIAL

NEW LDL-ADVANCE™ ASSAY AVAILABLE FROM DCL

DCL LAUNCHES NEW HDL-ADVANCE™ ASSAY

DCL OFFERS OEM & CONTRACT MANUFACTURING SERVICES TO THE IVD INDUSTRY

DCL OFFERS ON-LINE QUALITY CONTROL PROGRAM

DCL RECEIVES 510(K) APPROVAL FOR NEW LIQUID STABLE AMMONIA L3K^® REAGENT